Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma.

Lee, Hyunjong; Choi, Joon Young; Joung, Je-Gun; Joh, Jae-Won; Kim, Jong Man; Hyun, Seung Hyup

Lee, Hyunjong; Choi, Joon Young; Joung, Je-Gun; Joh, Jae-Won; Kim, Jong Man; Hyun, Seung Hyup.

Afiliação

Lee H; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Choi JY; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Joung JG; Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Joh JW; Department of Biomedical Science, College of Life Science, CHA University, Seongnam, South Korea.
Kim JM; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Hyun SH; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Front Oncol ; 12: 845900, 2022.

Article em En | MEDLINE | ID: mdl-35174098

Palavras-chave

FDG PET/CT; gene signatures; glucose metabolism; hepatocellular carcinoma; lipid metabolism; prognosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google